| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/10/2007 | WO2004103296A3 Methods of treating idiopathic pulmonary fibrosis |
| 05/10/2007 | WO2004064539A3 Fat substitutes |
| 05/10/2007 | US20070105955 Compounds for the treatment of metabolic disorders |
| 05/10/2007 | US20070105944 Taxane metabolites |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105931 Methods and compositions for inhibiting the proliferation of prostate cancer cells |
| 05/10/2007 | US20070105918 Use of Pramipexole to Treat Amyotrophic Lateral Sclerosis |
| 05/10/2007 | US20070105916 Amphiphilic pyridinium compounds, method of making and use thereof |
| 05/10/2007 | US20070105914 Substituted sulfonamides |
| 05/10/2007 | US20070105902 4-Phenyl piperdine sulfonyl glycine transporter inhibitors |
| 05/10/2007 | US20070105879 Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6 (9h)-one crystals; pharmaceutical presentation as a closed system ready-for-use; uses and methods |
| 05/10/2007 | US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105843 Combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 05/10/2007 | US20070105824 Methods for treating degenerative diseases/injuries |
| 05/10/2007 | US20070105109 Sirt1 and genetic disorders |
| 05/10/2007 | US20070104759 Sustained release inserts; mixture of thermoplastic polyester, solvent and leuprolide acetate; prostate cancer |
| 05/10/2007 | US20070104714 Composition and method for the treatment of cancer and other physiologic conditins based on modulation of the ppar-gamma pathway and her-kinase axis |
| 05/10/2007 | US20070104702 Method for treating diseases associated with changes of qualitative and/quantitative composition of blood extracellular dna |
| 05/10/2007 | US20070104696 Use of cell lines to produce active therapeutic proteins |
| 05/10/2007 | US20070104686 Vaccines, immunotherapeutics and methods for using the same |
| 05/09/2007 | EP1782813A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 05/09/2007 | EP1597238B1 Hiv replication inhibiting pyrimidines and triazines |
| 05/09/2007 | EP1578375A4 Boron coated straw neutron detector |
| 05/09/2007 | EP1446131B1 Use of specific dose of fondaparinux sodium for the treatment of acs |
| 05/09/2007 | CN1960704A Composition, compising hydrofluoric acid, for inhibiting dental erosion |
| 05/09/2007 | CN1314390C Pharmaceutical dosage form with multiple coatings |
| 05/08/2007 | US7214696 Administering compounds such as -Carboxy-2-(3,5-difluorophenyl)-benzoxazole for therapy of transthyretin amyloid disease |
| 05/08/2007 | US7214695 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214519 Identifying modulators associated with heme independent inhibition of soluble guanylyl cyclase for use in treatment of infection, hypertension and cardiovascular disorders |
| 05/08/2007 | US7214493 For therapy of cancer |
| 05/08/2007 | US7214390 topical or transdermal mixtures comprising methyl nicotinate, L-arginine, plant extracts and carriers, used as sex response intensifiers |
| 05/08/2007 | US7214382 Self-warming or self-heating cosmetic and dermatological compositions and method of use |
| 05/08/2007 | US7214370 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 05/08/2007 | US7214368 Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene |
| 05/08/2007 | CA2248805C Low residue antiperspirant stick composition |
| 05/03/2007 | WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 05/03/2007 | WO2005007073A3 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 05/03/2007 | WO2004093778A3 Oligonucleotides that block toll-like receptors |
| 05/03/2007 | WO2004084820A3 Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
| 05/03/2007 | US20070100001 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 05/03/2007 | US20070099952 Hif-1 inhibitors |
| 05/03/2007 | US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents |
| 05/03/2007 | US20070099926 Combination therapy for treating chronic inflammatory diseases |
| 05/03/2007 | US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 05/03/2007 | US20070099901 Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 05/03/2007 | US20070099884 Combination therapy for the treatment of diabetes |
| 05/03/2007 | US20070099185 Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein |
| 05/03/2007 | US20070098765 Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 05/03/2007 | US20070098638 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications |
| 05/02/2007 | EP1779725A1 Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 05/02/2007 | EP1778246A2 Pharmaceutical composition comprising polymorphic forms of dehydroepiandrosterone |
| 05/02/2007 | EP1628639A4 Antimicrobial quaternary ammonium organosilane coatings |
| 05/02/2007 | EP1594835A4 Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses |
| 05/02/2007 | EP1575565A4 Modified-release tablet of bupropion hydrochloride |
| 05/02/2007 | EP1499589B1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
| 05/02/2007 | EP1144675A4 Pharmacokinetic-based drug design tool and method |
| 05/02/2007 | CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors |
| 05/02/2007 | CN1956968A Aryl glycinamide derivatives and their use as NK1 antagonists and 5-serotonin reuptake inhibithors |
| 05/02/2007 | CN1956949A Substituted sulfonamides |
| 05/02/2007 | CN1956705A Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease |
| 05/02/2007 | CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 05/02/2007 | CN1313152C Vaccines |
| 05/02/2007 | CN1313147C Treatment of inner ear hair cells |
| 05/02/2007 | CN1313077C Anhydrous composition for bleaching keratin fibers |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211260 Infectious bursitis vaccine |
| 05/01/2007 | US7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody |
| 05/01/2007 | US7211249 Heat-generating composition for topical application to skin |
| 05/01/2007 | US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand |
| 04/26/2007 | WO2005051314A3 Iraks as modifiers of branching morphogenesis and methods of use |
| 04/26/2007 | WO2005051311A3 Enuresis device with magnetic fastener |
| 04/26/2007 | WO2005034847A3 Methods of reducing risk of infection from pathogens |
| 04/26/2007 | US20070093903 Spine replacement system for the treatment of spine instability and degenerative disc disease |
| 04/26/2007 | US20070093645 Peptide vectors |
| 04/26/2007 | US20070093544 1-((4-Tert-butylcyclohexyl)(1-methyl-5-propoxy-1H-benzimidazol-2-yl-amino-)-N-1H-tetrazole-5-yl-indane-5-carboxamide; glucagon receptor antagonists; antidiabetic agents; type 2 diabetes mellitus; insulin resistance; gluconeogenesis inhibitors; lowering rate of hepatic glucose output; hypoglycemic agents |
| 04/26/2007 | US20070093537 Thiazolyl-based compounds useful as kinase inhibitors |
| 04/26/2007 | US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 04/26/2007 | US20070093453 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 04/26/2007 | US20070093434 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 04/26/2007 | US20070092936 Severe acute respiratory syndrome |
| 04/26/2007 | US20070092629 Quinoa protein concentrate, production and functionality |
| 04/26/2007 | US20070092574 Controlled released compositions |
| 04/26/2007 | US20070092538 Immunogenic reagents from west nile virus |
| 04/26/2007 | US20070092488 Methods of treating idiopathic pulmonary fibrosis |
| 04/26/2007 | US20070092444 Inhibition of inward sodium currents in cancer |
| 04/25/2007 | EP1776962A1 Vaccine |
| 04/25/2007 | EP1587951A4 Substrate detection assay |
| 04/25/2007 | CN1953772A Contrast medium for receptor of angiotensin ii |
| 04/25/2007 | CN1952119A Blood cell production via activation of the hemoglobin scavenger receptor |
| 04/25/2007 | CN1951965A Glp－1衍生物 Glp-1 derivatives |
| 04/25/2007 | CN1951412A Nitric oxide and its biomedical significance |
| 04/25/2007 | CN1951411A Nitric oxide and its biomedical significance |
| 04/25/2007 | CN1951371A Immediate release tablet |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/24/2007 | USRE39585 Administering streptococcus thermophilus in admixture withLactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum or Bifidobacterium breve |
| 04/24/2007 | US7209787 Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
| 04/24/2007 | CA2289574C 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |